PARP inhibitor combo shows early promise for patients with and without BRCA mutations
PARP inhibitor combo shows early promise for patients with and without BRCA mutations
US breast cancer cases expected to increase by as much as 50 percent
DNA stool test recommended as screening tool for colon cancer
How is ganetespib regulating the response of tumour cells in lung cancer?
Incidences of liver cancer rising in the USA
Black women found to have denser breast tissue than white women
Prevention of gynaecological cancers: in memory of Mario Sideri
Pembrolizumab showed clinical benefit in malignant pleural mesothelioma
New approaches in computational pathology for risk assessment in benign breast diseases
Latest trials and outcomes with new CLL treatments
Developing treatments for indolent non hodgkin lymphoma
Developments in immunotherapy